[1. C. V. Pardeshi, P. V. Rajput, V. S. Belgamwar and A. R. Tekade, Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for valsartan, J. Microencapsul. 29 (2011) 103-114; DOI: 10.3109/02652048.2011.630106.10.3109/02652048.2011.630106]Search in Google Scholar
[2. W. Mehnert and K. Mader, Solid lipid nanoparticles: Production, characterization and applications, Adv. Drug. Del. Rev. 47 (2001) 165-196; DOI: 10.1016/S0169-409X(01)00105-3.10.1016/S0169-409X(01)00105-3]Search in Google Scholar
[3. S. Mukherjee, S. Ray and R. S. Thakur, Solid lipid nanoparticles: A modern formulation approach in drug delivery system, Ind. J. Pharm. Sci. 71 (2009) 349-358.]Search in Google Scholar
[4. R. H. Müller, K. Mäder and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art, Eur. J. Pharm. Biopharm. 50 (2000) 161-177.10.1016/S0939-6411(00)00087-4]Search in Google Scholar
[5. R. H. Müller, M. Radtke and S. A. Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs, Int. J. Pharm. 242 (2002) 121-128; DOI: 10.1016/S0378-5173(02)00180-1.10.1016/S0378-5173(02)00180-1]Search in Google Scholar
[6. R. H. Müller, M. Radtke and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv. Drug Del. Rev. 54 (Suppl. 1) (2002) S131-S155; DOI: 10.1016/S0169-409X(02)00118-7.10.1016/S0169-409X(02)00118-7]Search in Google Scholar
[7. R. H. Müller, R. D. Petersen, A. Hommoss and J. Pardeike, Nanostructured lipid carriers (NLC) for cosmetic dermal products, Adv. Drug Del. Rev. 59 (2007) 522-530; DOI: 10.1016/j.addr.2007.04.012.10.1016/j.addr.2007.04.01217602783]Search in Google Scholar
[8. J. Y. Fang, C. L. Fang, C. H. Liu and Y. H. Su, Lipid nanoparticles as vehicles for psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers, Eur. J. Pharm. Biopharm. 70 (2008) 633-640; DOI: 10.1016/j.ejpb.2008.05.008.10.1016/j.ejpb.2008.05.00818577447]Search in Google Scholar
[9. E. B. Souto, S. A. Wissing, C. M. Barbosa and R. H. Müller, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery, Int. J. Pharm. 278 (2004) 71-77; DOI: 10.1016/j.ijpharm.2004.02.032.10.1016/j.ijpharm.2004.02.03215158950]Search in Google Scholar
[10. M. Joshi and V. Patravale, Nanostructured lipid carriers (NLC) based gel of celecoxib, Int. J. Pharm. 346 (2008) 124-132; DOI: 10.1016/j.ijpharm.2007.05.060.10.1016/j.ijpharm.2007.05.06017651933]Search in Google Scholar
[11. V. Teeranachaideekul, R. H. Müller and V. B. Junyaprasert, Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) - Effect of formulation parameters on physicochemical stability, Int. J. Pharm. 340 (2007) 198-206; DOI: 10.1016/j.ijpharm.2007.03.022.10.1016/j.ijpharm.2007.03.02217482778]Search in Google Scholar
[12. S. Doktorovova, J. Araujo, M. L. Garcia, E. Rakovsky and E. B. Souto, Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC), Colloid Surfacec B. 75 (2010) 538-542; DOI: 10.1016/j.colsurfb.2009.09.033.10.1016/j.colsurfb.2009.09.033]Search in Google Scholar
[13. C. Olbrich, A. Gessner, W. Schroder, O. Kayser and R. H. Müller, Lipid-drug conjugate of the hydrophilic drug diminazine-cytotoxicity testing and mouse serum adsorption, J. Control. Release 96 (2004) 425-435; DOI: 10.1016/j.jconrel.2004.02.024.10.1016/j.jconrel.2004.02.024]Search in Google Scholar
[14. H. L. Wong, A. M. Rauth, R. Bendayan and X. Y. Wu, In-vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model, Eur. J. Pharm. Biopharm. 65 (2007) 300-308; DOI: 10.1016/j.ejpb.2006.10.022.10.1016/j.ejpb.2006.10.022]Search in Google Scholar
[15. H. L. Wong, A. M. Rauth, R. Bendayan and X. Y. Wu, Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment for multidrug-resistant breast cancer, J. Control. Release 116 (2006) 275-284; DOI: 10.1016/j.jconrel.2006.09.007.10.1016/j.jconrel.2006.09.007]Search in Google Scholar
[16. L. Zhang, J. M. Chan, F. X. Gu, A. Z. Wang, A. F. Radovic-Moreno, F. Alexis, R. Langer and O. C. Farokhzad, Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform, ACS Nano. 2 (2008) 1696-1702; DOI: 10.1021/nn800275r.10.1021/nn800275r]Search in Google Scholar
[17. Y. Li, H. L. Wong, A. J. Shuhendler, A. M. Rauth and X. Y. Wu, Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles, J. Control. Release. 128 (2008) 60-70; DOI: 10.1016/j.jconrel.2008.02.014.10.1016/j.jconrel.2008.02.014]Search in Google Scholar
[18. C. Salvador-Morales, L. Zhang, R. Langer and O. C. Farokhzad, Immunocompatibility properties of polymer-lipid hybrid nanoparticles with heterogeneous surface functional groups, Biomaterials 30 (2009) 2231-2240; DOI: 10.1016/j.biomaterials.2009.01.005.10.1016/j.biomaterials.2009.01.005]Search in Google Scholar
[19. R. Lander, W. Manger, M. Scouloudis, A. Ku, C. Davis and A. Lee, Gaulin homogenization: a mechanistic study, Biotechnol. Prog. 16 (2000) 80-85; DOI: 10.1021/bp990135c.10.1021/bp990135c]Search in Google Scholar
[20. R. H. Müller, S. Benita and B. Bohm, Emulsions and nanosuspensions for the formulation of poorly soluble drugs, Int. J. Pharm. 212 (2001) 143-144.10.1016/S0378-5173(00)00604-9]Search in Google Scholar
[21. B. Siekmann and K. Westesen, Solid lipid nanoparticles stabilized by tyloxapol, Eur. J. Pharm. Sci. 2 (1994) 117-194; DOI: 10.1016/0928-0987(94)90407-3.10.1016/0928-0987(94)90407-3]Search in Google Scholar
[22. H. Bunjes, B. Siekmann and K. Westesen, Emulsions of supercooled melts-a novel drug delivery system, in Submicron Emulsions in Drug Targeting and Delivery, Ed. S. Benita, Hardwood Academic Publishers, Amsterdam 1998, pp. 175-204.10.1201/9780367810528-7]Search in Google Scholar
[23. V. Venkateswarlu and K. Manjunath, Preparation, characterization and in-vitro release kinetics of clozapine solid lipid nanoparticles, J. Control. Release 95 (2004) 627-638; DOI: 10.1016/j.jconrel.2004.01.005.10.1016/j.jconrel.2004.01.005]Search in Google Scholar
[24. S. Gande, V. Vobalaboina, M. Kopparam, V. Venkateswarlu and S. Vemula, Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles, AAPS PharmSciTech. 8 (2007) E1-E9.10.1208/pt0801024]Search in Google Scholar
[25. S. P. Vyas and R. K. Khar, Targeted and Controlled Drug Delivery: A Novel Carrier System, 1st ed., CBS Publishers and Distributors, New Delhi 2002, pp. 346-348.]Search in Google Scholar
[26. S. Xie, L. Zhu, Z. Dong, X. Wang, Y. Wang, X. Li and W. Zhou, Preparation, characterization and pharmacokinetics of enrofloxacin loaded solid lipid nanoparticles: Influences of fatty acids, Colloid Surface B 83 (2011) 382-387; DOI: 10.1016/j.colsurfb.2010.12.014; DOI: 10.1016/j.colsurfb.2010.12.014.]Search in Google Scholar
[27. A. V. Heydenreich, R. Westmeier, N. Pedersen, H. S. Poulsen and H. G. Kristensen, Preparation and purification of cationic solid lipid nanospheres-effects on particle size, physical stability and cell toxicity, Int. J. Pharm. 254 (2003) 83-87; DOI: 10.1016/S0378-5173(02)00688-9.10.1016/S0378-5173(02)00688-9]Search in Google Scholar
[28. N. K. Jain, Advances in Controlled and Novel Drug Delivery, 1st ed., CBS Publishers and Distributors, New Delhi 2001, pp. 418-424.]Search in Google Scholar
[29. H. Zhou, T. Gu, D. Yang, Z. Jiang and J. Zeng, Griseofulvin solid lipid nanoparticles based on microemulsion technique, Adv. Mater. Res. 197-198 (2011) 47-50; DOI: 10.4028/www.scientific.net/AMR.197-198.47.10.4028/www.scientific.net/AMR.197-198.47]Search in Google Scholar
[30. M. R. Gasco and L. P. Antonelli, Method for producing solid lipid nanospheres having a narrow size distribution, US Pat. 5,250,236, 05 Oct. 1993.]Search in Google Scholar
[31. S. Morel, M. R. Gasco and R. Cavalli, Incorporation in lipospheres of [D-Trp-6]LHRH, Int. J. Pharm. 105 (1994) RI-R3; DOI: 10.1016/0378-5173(94)90466-9.10.1016/0378-5173(94)90466-9]Search in Google Scholar
[32. S. Morel, E. Ugazio, R. Cavalli and M. R. Gasco, Thymopentin in solid lipid nanoparticles, Int. J. Pharm. 132 (1996) 259-261; DOI: 10.1016/0378-5173(95)04388-8.10.1016/0378-5173(95)04388-8]Search in Google Scholar
[33. T. Hammady, A. El-Gindy, E. Lejmi, R. S. Dhanikula, P. Moreau and P. Hildgen, Characteristics and properties of nanospheres co-loaded with lipophilic and hydrophilic drug models, Int. J. Pharm. 369 (2009) 185-195; DOI: 10.1016/j.ijpharm.2008.10.034.10.1016/j.ijpharm.2008.10.034]Search in Google Scholar
[34. M. Trotta, F. Debernardi and O. Caputo, Preparation of solid lipid nanoparticles by solvent emulsification-diffusion technique, Int. J. Pharm. 257 (2003) 153-160; DOI: 10.1016/S0378-5173(03)00135-2.10.1016/S0378-5173(03)00135-2]Search in Google Scholar
[35. L. Battaglia, M. Trotta, M. M. E. G. P. A. Solid lipid nanoparticles formed by solvent-in-eater emulsion-diffusion technique, J. Microencapsul. 5 (2009) 394-402.]Search in Google Scholar
[36. H. Yuan, L. F. Huang, Y. Z. Du, X. Y. Ying, J. You, F. Q. Hu and S. Zeng, Solid lipid nanoparticles prepared by solvent diffusion method in nanoreactor system, Colloid Surface B 61 (2008) 132-137; DOI: 10.1016/j.colsurfb.2007.07.015.10.1016/j.colsurfb.2007.07.01517888636]Search in Google Scholar
[37. J. Jaiswal, S. K. Gupta and J. Kreuter, Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process, J. Control Release 96 (2004) 169-178; DOI: 10.1016/j.jconrel.2004.01.017.10.1016/j.jconrel.2004.01.017]Search in Google Scholar
[38. B. Sjostrom and B. Bergenstahl, Preparation of submicron drug particles in lecithin stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate, Int. J. Pharm. 88 (1992) 53-62; DOI: 10.1016/0378-5173(92)90303-J.10.1016/0378-5173(92)90303-J]Search in Google Scholar
[39. K. Okuyama, M. Abdullah, I. W. Lenggoro and F. Iskandar, Preparation of functional nanostructured particles by spray drying, Adv. Powder Technol. 17 (2006) 587-611; DOI: 10.1163/156855206778917733.10.1163/156855206778917733]Search in Google Scholar
[40. K. Okuyama and I. W. Lenggoro, Preparation of nanoparticles via spray route, Chem. Eng. Sci. 58 (2003) 537-547; DOI: 10.1016/S0009-2509(02)00578-X.10.1016/S0009-2509(02)00578-X]Search in Google Scholar
[41. P. Luo and T. G. Nieh, Synthesis of ultrafine hydroxyapatite particles by spray dry method, Mater. Sci. Eng. C 3 (1995) 75-78; DOI: 10.1016/0928-4931(95)00089-5.10.1016/0928-4931(95)00089-5]Search in Google Scholar
[42. C. Freitas and R. H. Müller, Spray-drying of solid lipid nanoparticles (SLNTM), Eur. J. Pharm. Biopharm. 46 (1998) 145-151; DOI: 10.1016/S0939-6411(97)00172-0.10.1016/S0939-6411(97)00172-0]Search in Google Scholar
[43. P. Tewa-Tange, S. Briancon and H. Fessi, Preparation of redispersible dry nanocapsules by means of spray-drying: Development and characterisation, Eur. J. Pharm. Sci. 30 (2007) 124-135; DOI: 10.1016/j.ejps.2006.10.006.10.1016/j.ejps.2006.10.006]Search in Google Scholar
[44. P. M. Gosselin, R. Thibert, M. Preda and J. N. McMullen, Polymorphic properties of micronized carbamazepine produced by RESS, Int. J. Pharm. 252 (2003) 225-233; DOI: 10.1016/S0378-5173(02)00649-X.10.1016/S0378-5173(02)00649-X]Search in Google Scholar
[45. A. J. Thote and R. B. Gupta, Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release, Nanomedicine 1 (2005) 85-90; DOI: 10.1016/j.nano.2004.12.001.10.1016/j.nano.2004.12.001]Search in Google Scholar
[46. J. Vandervoort and A. Ludwig, Preparation and evaluation of drug loaded gelatin nanoparticles for topical ophthalmic use, Eur. J. Pharm. Biopharm. 57 (2004) 251-261; DOI: 10.1016/S0939-6411(03)00187-5.10.1016/S0939-6411(03)00187-5]Search in Google Scholar
[47. R. Paliwal, S. Rai, B. Vaidya, K. Khatri, A. K. Goyal, N. Mishra, A. Mehta and S. P. Vyas, Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery, Nanomedicine 5 (2009) 184-191; DOI: 10.1016/j.nano.2008.08.003.10.1016/j.nano.2008.08.003]Search in Google Scholar
[48. C. Olbrich and R. H. Müller, Enzymatic degradation of SLN - Effect of surfactant and surfactant mixtures, Int. J. Pharm. 180 (1999) 31-39; DOI: 10.1016/S0378-5173(98)00404-9.10.1016/S0378-5173(98)00404-9]Search in Google Scholar
[49. C. C. Chen, T. H. Tsai, Z. R. Huang and J. Y. Fang, Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics, Eur. J. Pharm. Biopharm. 74 (2010) 474-482; DOI: 10.1016/j.ejpb.2009.12.008.10.1016/j.ejpb.2009.12.008]Search in Google Scholar
[50. S. Y. Xie, S. L. Wang, B. K. Zhao, C. Han, M. Wang and W. Z. Zhou, Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles, Colloid Surface B 67 (2008) 199-204; DOI: 10.1016/j.colsurfb.2008.08.018.10.1016/j.colsurfb.2008.08.018]Search in Google Scholar
[51. R. Cavalli, O. Caputo, M. E. Carlotti, M. Trotta, C. Scarnecchia and M. R. Gasco, Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles, Int. J. Pharm. 148 (1997) 47-54; DOI: 10.1016/S0378-5173(96)04822-3.10.1016/S0378-5173(96)04822-3]Search in Google Scholar
[52. C. Schwarz, W. Mehnert, J. S. Lucks and R. H. Müller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterisation and sterilization, J. Control Release 30 (1994) 83-96.10.1016/0168-3659(94)90047-7]Search in Google Scholar
[53. W. Abdelwahed, G. Degobert, S. Stainmesse and H. Fessi, Freeze-drying of nanoparticles: Formulation, process and storage considerations, Adv. Drug Del. Rev. 58 (2006) 1688-1713; DOI: 10.1016/j.addr.2006.09.017.10.1016/j.addr.2006.09.017]Search in Google Scholar
[54. S. D. Allison, Md. C. Molina and T. J. Anchordoquy, Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis, Biochim. Biophys. Acta. 1468 (2000) 127-138; DOI: 10.1016/S0005-2736(00)00251-0.10.1016/S0005-2736(00)00251-0]Search in Google Scholar
[55. J. H. Crowe, J. F. Carpenter and L. M. Crowe, The role of vitrification in anhydrobiosis, Annu. Rev. Physiol. 60 (1998) 73-103; DOI: 10.1146/annurev.physiol.60.1.73.10.1146/annurev.physiol.60.1.73]Search in Google Scholar
[56. K. Westesen, B. Siekmann and M. H. J. Koch, Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction, Int. J. Pharm. 93 (1993) 189-199; DOI: 10.1016/0378-5173(93)90177-H.10.1016/0378-5173(93)90177-H]Search in Google Scholar
[57. H. Bunjes, K. Westesen and M. H. J. Koch, Crystallization tendencies and polymorphic transitions in triglyceride nanoparticles, Int. J. Pharm. 129 (1996) 159-173; DOI: 10.1016/0378-5173(95)04286-5.10.1016/0378-5173(95)04286-5]Search in Google Scholar
[58. A. Z. Muhlen, C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism, Eur. J. Pharm. Biopharm. 45 (1998) 149-155.10.1016/S0939-6411(97)00150-1]Search in Google Scholar
[59. S. Chakraborty, D. Shukla, B. Mishra and S. Singh, Lipid - An emerging platform for oral delivery of drugs with poor bioavailability, Eur. J. Pharm. Biopharm. 73 (2009) 1-15; DOI: 10.1016/j.ejpb.2009.06.001.10.1016/j.ejpb.2009.06.001]Search in Google Scholar
[60. A. Radomska-Soukharev, Stability of lipid excipients in solid lipid nanoparticles, Adv. Drug Del. Rev. 59 (2007) 411-418; DOI: 10.1016/j.addr.2007.04.004.10.1016/j.addr.2007.04.004]Search in Google Scholar
[61. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust and J. P. Benoit, Physico-chemical stability of colloidal lipid particles, Biomaterials 24 (2003) 4283-4300; DOI: 10.1016/S0142-9612(03)00331-4.10.1016/S0142-9612(03)00331-4]Search in Google Scholar
[62. B. Siekmann and K. Westesen, Thermoanalysis of recrystallization process of melt homogenised glyceride nanoparticles, Colloid Surface B 3 (1994) 159-175.10.1016/0927-7765(94)80063-4]Search in Google Scholar
[63. C. Freitas and R. H. Müller, Effect of light and temperature on zeta potential and physical stability of solid lipid nanoparticle (SLNTM) dispersions, Int. J. Pharm. 168 (1998) 221-229.10.1016/S0378-5173(98)00092-1]Search in Google Scholar
[64. C. Freitas and R. H. Müller, Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte, J. Microencapsul. 16 (1999) 59-71; DOI: 10.1080/026520499289310.10.1080/026520499289310]Search in Google Scholar
[65. C. Freitas and R. H. Müller, Correlation between long term stability of solid lipid nanoparticles (SLNTM) and crystallinity of lipid phase, Eur. J. Pharm. Biopharm. 47 (1999) 125-132.10.1016/S0939-6411(98)00074-5]Search in Google Scholar
[66. K. Westesen and B. Siekmann, Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles, Int. J. Pharm. 151 (1997) 35-45; DOI: 10.1016/S0378-5173(97)04890-4.10.1016/S0378-5173(97)04890-4]Search in Google Scholar
[67. R. H. Müller and S. Heinemann, Fat emulsions for parenteral nutrition. III. Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with low electrolyte load, Int. J. Pharm. 101 (1994) 175-189; DOI: 10.1016/0378-5173(94)90213-5.10.1016/0378-5173(94)90213-5]Search in Google Scholar
[68. C. Freitas, J. Lucks and R. H. Müller, Effect of storage conditions on long-term stability of »solid lipid nanoparticles« (SLN) in aqueous dispersion, Eur. J. Pharm. Sci. 2 (1994) 117-194; DOI: 10.1016/0928-0987(94)90411-1.10.1016/0928-0987(94)90411-1]Search in Google Scholar
[69. B. Borgstrom, Importance of phospholipids, pancreatic phospholipase A2, and fatty acid for the digestion of dietary fat: in vitro experiments with the porcine enzymes, Gastroenterology 78 (1980) 954-962.]Search in Google Scholar
[70. R. O. Scow and T. Olivecrona, Effect of albumin on products formed from chylomicron triacylglycerol by lipoprotein lipase in vitro, Biochim. Biophys. Acta. 487 (1977) 472-486; DOI: 10.1016/0005-2760(77)90217-X.10.1016/0005-2760(77)90217-X]Search in Google Scholar
[71. R. Pandey, S. Sharma and G. K. Khuller, Oral solid lipid nanoparticle-based antitubercular chemotherapy, Tuberculosis 85 (2005) 415-420, DOI: 10.1016/j.tube.2005.08.009.10.1016/j.tube.2005.08.009]Search in Google Scholar
[72. N. Zhang, Q. Ping, G. Huang, W. Xua, Y. Cheng and X. Han, Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin, Int. J. Pharm. 327 (2006) 153-159; DOI: 10.1016/j.ijpharm.2006.07.026.10.1016/j.ijpharm.2006.07.026]Search in Google Scholar
[73. M. D. Joshi and R. H. Müller, Lipid nanoparticles for parenteral delivery of actives, Eur. J. Pharm. Biopharm. 71 (2009) 161-172; DOI: 10.1016/j.ejpb.2008.09.003.10.1016/j.ejpb.2008.09.003]Search in Google Scholar
[74. S. A. Wissing, O. Kayser and R. H. Müller, Solid lipid nanoparticles for parenteral drug delivery, Adv. Drug Del. Rev. 56 (2004) 1257-1272; DOI: 10.1016/j.addr.2003.12.002.10.1016/j.addr.2003.12.002]Search in Google Scholar
[75. A. Fundarò, O, R. Cavalli, A. Bargoni, D. Vighetto, G. P. Zara and M. R. Gasco, Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue Distribution after i.v. administration to rats, Pharmacol. Res. 42 (2000) 337-343; DOI: 10.1006/phrs.2000.0695.10.1006/phrs.2000.0695]Search in Google Scholar
[76. S. C. Yang, L. F. Lu, Y. Cai, J. B. Zhu, B. W. Liang and C. Z. Yanga, Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain, J. Control. Release 59 (1999) 299-307; DOI: 10.1016/S0168-3659(99)00007-3.10.1016/S0168-3659(99)00007-3]Search in Google Scholar
[77. L. H. Reddy, R. K. Sharma, K. Chuttani, A. K. Mishra and R. S. R. Murthy, Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice, J. Control. Release 105 (2005) 185-198; DOI: 10.1016/j.jconrel.2005.02.028.10.1016/j.jconrel.2005.02.02815921775]Search in Google Scholar
[78. M. Schafer-Korting, W. Mehnert and H. C. Korting, Lipid nanoparticles for improved topical application of drugs for skin diseases, Adv. Drug Del. Rev. 59 (2007) 427-443; DOI: 10.1016/j.addr.2007.04.006.10.1016/j.addr.2007.04.006]Search in Google Scholar
[79. V. Jenning, M. Schafer-Korting and S. Gohla, Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties, J. Control. Release 66 (2000) 115-126; DOI: 10.1016/S0168-3659(99)00007-3.10.1016/S0168-3659(99)00007-3]Search in Google Scholar
[80. P. V. Pople and K. K. Singh, Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A, AAPS PharmSciTech. 4 (2006) E1-E7; DOI: 10.1208/pt070491.10.1208/pt070491275032817285742]Search in Google Scholar
[81. S. K. Jain, M. K. Chourasia, R. Masuriha, V. Soni, A. Jain, Nitin K. Jain and Y. Gupta, Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery, Drug Del. 12 (2005) 207-215; DOI: 10.1080/10717540590952591.10.1080/1071754059095259116036715]Search in Google Scholar
[82. A. J. Almeida and E. Souto, Solid lipid nanoparticles as a drug delivery system for peptides and proteins, Ad.v Drug Del. Rev. 59 (2007) 478-490; DOI: 10.1016/j.addr.2007.04.007.10.1016/j.addr.2007.04.00717543416]Search in Google Scholar
[83. J. Liu, T. Gong, H. Fu, C. Wang, X. Wang, Q. Chena, Q. Zhang, Q. Hea and Z. Zhang, Solid lipid nanoparticles for pulmonary delivery of insulin, Int. J. Pharm. 356 (2008) 333-344; DOI: 10.1016/j.ijpharm.2008.01.008.10.1016/j.ijpharm.2008.01.00818281169]Search in Google Scholar
[84. J. Araujo, E. Gonzalez, M. A. Egea, M. L. Garcia and E. B. Souto, Nanomedicines for ocular NSAIDs: safety on drug delivery, Nanomedicine 5 (2009) 394-401; DOI: 10.1016/j.nano.2009.02.003.10.1016/j.nano.2009.02.00319341814]Search in Google Scholar
[85. M. I. Alam, S. Beg, A. Samad, S. Baboota, K. Kohli, J. Ali, A. Ahuja and M. Akbar, Strategy for effective brain drug delivery, Eur. J. Pharm. Sci. 40 (2010) 385-403; DOI: 10.1016/j.ejps.2010.05.003.10.1016/j.ejps.2010.05.00320497904]Search in Google Scholar
[86. I. P. Kaur, R. Bhandari, S. Bhandari and V. Kakkar, Potential of solid lipid nanoparticles in brain targeting, J. Control. Release 127 (2008) 97-100; DOI: 10.1016/j.jconrel.2007.12.018.10.1016/j.jconrel.2007.12.01818313785]Search in Google Scholar
[87. A. Mistry, S. Stolnik and L. Illum, Nanoparticles for direct nose-to-brain delivery of drugs, Int. J. Pharm. 379 (2009) 146-157; DOI: 10.1016/j.ijpharm.2009.06.019.10.1016/j.ijpharm.2009.06.01919555750]Search in Google Scholar
[88. I. Brasnjevic, H. W. M. Steinbusch, C. Schmitz and P. Martinez-Martinez, Delivery of peptide and protein drugs over the blood-brain barrier, Prog. Neurobiol. 87 (2009) 212-251; DOI: 10.1016/j.pneurobio.2008.12.002.10.1016/j.pneurobio.2008.12.002]Search in Google Scholar
[89. F. Chellat, Y. Merhi, A. Moreau and L. H. Yahia, Therapeutic potential of nanoparticulate systems for macrophage targeting, Biomaterials 26 (2005) 7260-7275; DOI: 10.1016/j.biomaterials.2005.05.044.10.1016/j.biomaterials.2005.05.044]Search in Google Scholar
[90. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. Xu and X. Yang, Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting, J. Control. Release 110 (2006) 296-306; DOI: 10.1016/j.jconrel.2005.09.052.10.1016/j.jconrel.2005.09.052]Search in Google Scholar
[91. R. H. Müller, S. Maaben, H. Weyhers, F. Specht and J. S. Lucks, Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles, Int. J. Pharm. 138 (1996) 85-94; DOI: 10.1016/0378-5173(96)04539-5.10.1016/0378-5173(96)04539-5]Search in Google Scholar
[92. D. M. Radolfi, P. D. Marcato, R. A. Silva, G. Z. Justo and N. Duran, In vitro cytotoxicity assay of solid lipid nanoparticles in epithelial and dermal cells, J. Phys. Conf. Ser. 304 (2011) 1-4; DOI: 10.1088/1742-6596/304/1/012032.10.1088/1742-6596/304/1/012032]Search in Google Scholar
[93. H. Yuan, J. Miao, Y. Z. Du, J. You, F. Q. Hu and S. Zeng, Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells, Int. J. Pharm. 348 (2008) 137-145; DOI: 10.1016/j.ijpharm.2007.07.012.10.1016/j.ijpharm.2007.07.01217714896]Search in Google Scholar
[94. J. C. Olivier, Drug transport to brain with targeted nanoparticles, NeuroRx. 1 ( 2005) 108-119; DOI: 10.1602/neurorx.2.1.108.10.1602/neurorx.2.1.10853932915717062]Search in Google Scholar
[95. T. R. Pisanic II, J. D. Blackwell, V. I. Shubayev, R. R. Fiñones and S. Jin, Nanotoxicity of iron oxide nanoparticle internalization in growing neurons, Biomaterials 28 (2007) 2572-2581; DOI: 10.1016/j.biomaterials.2007.01.043.10.1016/j.biomaterials.2007.01.04317320946]Search in Google Scholar
[96. H. C. Fischer, W. C. Chan, Nanotoxicity: the growing need for in vivo study, Curr. Opin. Biotechnol. 18 (2007) 565-571; DOI: 10.1016/j.copbio.2007.11.008.10.1016/j.copbio.2007.11.00818160274]Search in Google Scholar
[97. Y. L. Hu and J. Q. Gao, Potential neurotoxicity of nanoparticles, Int. J. Pharm. 394 (2010) 115-121; DOI: 10.1016/j.ijpharm.2010.04.026.10.1016/j.ijpharm.2010.04.02620433914]Search in Google Scholar
[98. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann and K. Mäder, Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy, J. Control. Release 95 (2004) 217-227; DOI: 10.1016/j.jconrel.2003.11.012.10.1016/j.jconrel.2003.11.012]Search in Google Scholar
[99. S. Chakraborty, B. Sahoo, I. Teraoka and R. A. Gross, Solution properties of starch nanoparticles in water and DMSO as studied by dynamic light scattering, Carbohydr Polym. 60 (2005) 475-481; DOI: 10.1016/j.carbpol.2005.03.011.10.1016/j.carbpol.2005.03.011]Search in Google Scholar
[100. B. G. Zanetti-Ramos, M. B. Fritzen-Garcia, C. S. de Oliveira, A. A. Pasa, V. Soldi, R. Borsali and T. B. Creczynski-Pasa, Dynamic light scattering and atomic force microscopy techniques for size determination of polyurethane nanoparticles, Mater. Sci. Eng. C. Mater. Biol. App. 29 (2009) 638-640; DOI: 10.1016/j.msec.2008.10.040.10.1016/j.msec.2008.10.040]Search in Google Scholar
[101. L. Dulog and T. Schauer, Field flow fractionation for particle size determination, Prog. Org. Coat. 28 (1996) 25-31; DOI: 10.1016/0300-9440(95)00584-6.10.1016/0300-9440(95)00584-6]Search in Google Scholar
[102. A. S. Dukhin, P. J. Goetz, X. Fang and P. Somasundaran, Monitoring nanoparticles in the presence of larger particles in liquids using acoustics and electron microscopy, J. Colloid Inter. Sci. 342 (2010) 18-25; DOI: 10.1016/j.jcis.2009.07.001.10.1016/j.jcis.2009.07.001]Search in Google Scholar
[103. V. Jenning, K. Mäder and S. H. Gohla, Solid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: 1H-NMR study, Int. J. Pharm. 205 (2000) 15-21; DOI: 10.1016/S0378-5173(00)00462-2.10.1016/S0378-5173(00)00462-2]Search in Google Scholar
[104. A. Dubes, H. Parrot-Lopez, W. Abdelwahed, G. Degobert, H. Fessi, P. Shahgaldian and A. W. Coleman, Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins, Eur. J. Pharm. Biopharm. 55 (2003) 279-282; DOI: 10.1016/S0939-6411(03)00020-1.10.1016/S0939-6411(03)00020-1]Search in Google Scholar
[105. M. Albrecht, V. Janke, S. Sievers, U. Siegner, D. Schulerb and U. Heyen, Scanning force microscopy study of biogenic nanoparticles for medical applications, J. Magn. Magn. Mater. 290-291 (2005) 269-271; DOI: 10.1016/j.jmmm.2004.11.206.10.1016/j.jmmm.2004.11.206]Search in Google Scholar
[106. N. Škalko, J. Bouwstra, F. Spies, M. Stuart, P. M. Frederik and G. Gregoriadis, Morphological observations on liposomes bearing covalently bound protein: Studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques, Biochim. Biophys. Acta 1370 (1998) 151-160; DOI: 10.1016/S0005-2736(97)00256-3.10.1016/S0005-2736(97)00256-3]Search in Google Scholar
[107. K. Fowler, L. A. Bottomley and H. Schreier, Surface topography of phospholipid bilayer and vesicles (liposomes) by scanning tunnelling microscopy (STM), J. Control. Release 22 (1992) 283-292; DOI: 10.1016/0168-3659(92)90103-X.10.1016/0168-3659(92)90103-X]Search in Google Scholar
[108. O. Robach, C. Quiros, S. M. Valvidares, C. J. Walker and S. Ferrer, Structure and Pt magnetism of FePt nanoparticles investigated with X-ray diffraction, J. Magn. Magn. Mater. 264 (2003) 202-208; DOI: 10.1016/S0304-8853(03)00205-1.10.1016/S0304-8853(03)00205-1]Search in Google Scholar
[109. M. A. Schubert, B. C. Schicke and C. C. Muller-Goymann, Thermal analysis of the crystallization and melting behaviour of lipid matrices and lipid nanoparticles containing high amounts of lecithin, Int. J. Pharm. 298 (2005) 242-254; DOI: 10.1016/j.ijpharm.2005.04.014.10.1016/j.ijpharm.2005.04.014]Search in Google Scholar
[110. S. A. Wissing and R. H. Müller, Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration, J. Control. Release 81 (2002) 225-233; DOI: 10.1016/S0168-3659(02)00056-1.10.1016/S0168-3659(02)00056-1]Search in Google Scholar
[111. C. Song and S. Liu, A new healthy sunscreen system for human: Solid lipid nannoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding vitamin E, Int. J. Biol. Macromol. 36 (2005) 116-119; DOI: 10.1016/j.ijbiomac.2005.05.003.10.1016/j.ijbiomac.2005.05.003]Search in Google Scholar
[112. J. Pardeike, A. Hommoss and R. H. Müller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int. J. Pharm. 366 (2009) 170-184; DOI: 10.1016/j.ijpharm.2008.10.003.10.1016/j.ijpharm.2008.10.003]Search in Google Scholar
[113. S. A. Wissing and R. H. Müller, Cosmetic applications for solid lipid nanoparticles (SLN), Int. J. Pharm. 254 (2003) 65-68; DOI: 10.1016/S0378-5173(02)00684-1.10.1016/S0378-5173(02)00684-1]Search in Google Scholar
[114. K. A. Shah, A. A. Date, M. D. Joshi and V. B. Patravale, Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery, Int. J. Pharm. 345 (2007) 163-171; DOI: 10.1016/j.ijpharm.2007.05.061.10.1016/j.ijpharm.2007.05.06117644288]Search in Google Scholar
[115. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu and X. Yang, Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery, Int. J. Pharm. 328 (2007) 191-195; DOI: 10.1016/j.ijpharm.2006.08.007.10.1016/j.ijpharm.2006.08.00716978810]Search in Google Scholar
[116. M. S. Korting, W. Mehnert and H. C. Korting, Lipid nanoparticles for improved topical application of drugs for skin diseases, Adv. Drug Del. Rev. 59 (2007) 427-443; DOI: 10.1016/j.addr.2007.04.006.10.1016/j.addr.2007.04.00617544165]Search in Google Scholar
[117. A. del Pozo-Rodrigueza, D. Delgadoa, M. A. Solinis, J. L. Pedraza, E. Echevarria, J. M. Rodriguez and A. R. Gascona, Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration, Int. J. Pharm. 385 (2010) 157-162; DOI: 10.1016/j.ijpharm.2009.10.020.10.1016/j.ijpharm.2009.10.02019835940]Search in Google Scholar
[118. S. H. Choi, S. E. Jin, M. K. Lee, S. J. Lim, J. S. Park, B. G. Kim, W. S. Ahn and C. K. Kim, Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells, Eur. J. Pharm. Biopharm. 68 (2008) 545-554; DOI: 10.1016/j.ejpb.2007.07.011.10.1016/j.ejpb.2007.07.011]Search in Google Scholar
[119. N. Pedersen, S. Hansen, A. V. Heydenreich, H. G. Kristensen and H. S. Poulsen, Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands, Eur. J. Pharm. Biopharm. 62 (2006) 155-162; DOI: 10.1016/j.ejpb.2005.09.003.10.1016/j.ejpb.2005.09.003]Search in Google Scholar
[120. H. L. Wong, R. Bendayan, A. M. Rauth, Y. Li and X. Y. Wu, Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles, Adv. Drug Del. Rev. 59 (2007) 491-504; DOI: 10.1016/j.addr.2007.04.008.10.1016/j.addr.2007.04.008]Search in Google Scholar
[121. H. L. Wong, R. Bendayan, A. M. Rauth and X. Y. Wu, Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer, J. Control. Release 116 (2006) 275-284; DOI: 10.1016/j.jconrel.2006.09.007.10.1016/j.jconrel.2006.09.007]Search in Google Scholar
[122. R. K. Subedi, K. W. Kang and H. K. Choi, Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin, Eur. J. Pharm. Sci. 37 (2009) 508-513; DOI: 10.1016/j.ejps.2009.04.008.10.1016/j.ejps.2009.04.008]Search in Google Scholar
[123. B. Lu, S. B. Xiong, H. Yang, X. D. Yin and R. B. Chao, Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases, Eur. J. Pharm. Sci. 28 (2006) 86-95; DOI: 10.1016/j.ejps.2006.01.001.10.1016/j.ejps.2006.01.001]Search in Google Scholar
[124. N. Csaba, M. Garcia-Fuentes and M. J. Alonso, Nanoparticles for nasal vaccination, Adv. Drug Del. Rev. 61 (2009) 140-157; DOI: 10.1016/j.addr.2008.09.005.10.1016/j.addr.2008.09.005]Search in Google Scholar
[125. S. M. Moghimi and J. Szebeni, Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties, Prog. Lipid Res. 42 (2003) 463-478; DOI: 10.1016/S0163-7827(03)00033-X.10.1016/S0163-7827(03)00033-X]Search in Google Scholar
[126. Y. Wang and W. Wu, In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages, Drug Deliv. 3 (2006) 189-192; DOI: 10.1080/10717540-500-315330.]Search in Google Scholar
[127. M. R. Gasco, Lipid nanoparticles: perspectives and challenges, Adv. Drug Del. Rev. 59 (2007) 377-378; DOI: 10.1016/j.addr.2007.05.004.10.1016/j.addr.2007.05.004]Search in Google Scholar
[128. A. J. Domb, Long acting injectable oxytetracycline-liposphere formulations, Int. J. Pharm. 124 (1995) 271-278; DOI: 10.1016/0378-5173(95)00098-4.10.1016/0378-5173(95)00098-4]Search in Google Scholar
[129. C. Schwarz and W. Mehnert, Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN), Int. J. Pharm. 157 (1997) 171-179; DOI: 10.1016/S0378-5173(97)00222-6.10.1016/S0378-5173(97)00222-6]Search in Google Scholar
[130. K. Westesen, H. Bunjes and M. H. J. Koch, Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential, J. Control. Release 48 (1997) 223-236; DOI: 10.1016/S0168-3659(97)00046-1.10.1016/S0168-3659(97)00046-1]Search in Google Scholar
[131. K. Westesen, B. Siekmann and M. H. J. Koch, Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction, Int. J. Pharm. 93 (1993) 189-199; DOI: 10.1016/0378-5173(93)90177-H.10.1016/0378-5173(93)90177-H]Search in Google Scholar
[132. A. J. Almeida, S. Runge and R. H. Müller, Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters, Int. J. Pharm. 149 (1997) 255-265; DOI: 10.1016/S0378-5173(97)04885-0.10.1016/S0378-5173(97)04885-0]Search in Google Scholar
[133. R. Cavalli, E. Peira, O. Caputo and M. R. Gasco, Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with a-cyclodextrins, Int. J. Pharm. 182 (1999) 59-69.10.1016/S0378-5173(99)00066-6]Search in Google Scholar
[134. H. Ali, A. B. Shirode, P. W. Sylvester and S. Nazzal, Preparation and in vitro antiproliferative effect of tocotrienol loaded lipid nanoparticles, Colloid Surface A 353 (2010) 43-51; DOI: 10.1016/j.colsurfa.2009.10.020.10.1016/j.colsurfa.2009.10.020]Search in Google Scholar
[135. R. Cavalli, S. Morel, M. R. Gasco, P. Chetoni and M. F. Saettone, Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair, Int. J. Pharm. 117 (1995) 243-246; DOI: 10.1016/0378-5173(94)00339-7.10.1016/0378-5173(94)00339-7]Search in Google Scholar
[136. S. Morel, E. Terreno, E. Ugazio, S. Aime and M. R. Gasco, NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes, Eur. J. Pharm. Biopharm. 45 (1998) 157-163; DOI: 10.1016/S0939-6411(97)00107-0.10.1016/S0939-6411(97)00107-0]Search in Google Scholar
[137. M. R. Gasco, R. Cavalli and M. E. Carlotti, Timolol in lipospheres, Pharmazie 47 (1992) 119-121.]Search in Google Scholar
[138. A. A. Attama and C. C. Müller-Goymann, Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity, Colloid Surface A 315 (2008) 189-195; DOI: 10.1016/j.colsurfa.2007.07.035.10.1016/j.colsurfa.2007.07.035]Search in Google Scholar
[139. S. Kheradmandia, E. Vasheghani-Farahani, M. Nosrati and F. Atyabi, Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax, Nanomedicine 6 (2010) 753-759; DOI: 10.1016/j.nano.2010.06.003.10.1016/j.nano.2010.06.00320599527]Search in Google Scholar
[140. B. D. Kim, K. Na and H. K. Choi, Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan, Eur. J. Pharm. Sci. 24 (2005) 199-205; DOI: 10.1016/j.ejps.2004.10.008.10.1016/j.ejps.2004.10.008]Search in Google Scholar
[141. C. Bocca, O. Caputo, R. Cavalli, L. Gabrial, A. Miglietta and M. R. Gasco, Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles, Int. J. Pharm. 175 (1998) 185-193; DOI: 10.1016/S0378-5173(98)00282-8.10.1016/S0378-5173(98)00282-8]Search in Google Scholar
[142. T. M. Goppert and R. H. Müller, Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN), Eur. J. Pharm. Biopharm. 60 (2005) 361-372; DOI: 10.1016/j.ejpb.2005.02.006.10.1016/j.ejpb.2005.02.006]Search in Google Scholar
[143. H. M. Redhead, S. S. Davis and L. Illum, Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation, J. Control. Release 70 (2001) 353-363.]Search in Google Scholar
[144. C. Olbrich, O. Kayser and R. H. Müller, Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN) - effect of surfactants, storage time and crystallinity, Int. J. Pharm. 237 (2002) 119-128; DOI: 10.1016/S0378-5173(02)00035-2.10.1016/S0378-5173(02)00035-2]Search in Google Scholar
[145. C. C. Shen, W. L. Tseng and M. M. Hsieh, Selective enrichment of aminothiols using polysorbate 20-capped gold nanoparticles followed by capillary electrophoresis with laser-induced fluorescence, J. Chromatogr. A 1216 (2009) 288-293; DOI: 10.1016/j.chroma.2008.11.044.10.1016/j.chroma.2008.11.044]Search in Google Scholar
[146. L. D. Marzio, C. Marianecci, M. Petrone, F. Renaldi and M. Carafa, Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20, Colloid Surface B 82 (2011) 18-24; DOI: 10.1016/j.colsurfb.2010.08.004.10.1016/j.colsurfb.2010.08.004]Search in Google Scholar
[147. L. H. Reddy, K. Vivek, N. Bakshi and R. S. R. Murthy, Tamoxifen citrate loaded solid lipid nanoparticles (SLN™): Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation, Pharm. Dev. Technol. 11 (2006) 167-177; 2006, DOI: 10.1080/10837450600561265.10.1080/10837450600561265]Search in Google Scholar
[148. F. Q. Hu, H. Yuan, H. H. Zhang and M. Fang, Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization, Int. J. Pharm. 239 (2002) 121-128; DOI: 10.1016/S0378-5173(02)00081-9. 10.1016/S0378-5173(02)00081-9]Search in Google Scholar